Selbyville, Delaware, March 8, 2022 (GLOBE NEWSWIRE) —
The animal model market value is expected to exceed USD 30.6 billion by 2028, according to a new research report from Global Market Insights Inc. Rising prevalence of infectious diseases is expected to drive industry growth.
Animal models are used in several application areas of medical research, such as the study of disease pathogenesis, drug safety and efficacy testing, and vaccine development. They have proven to be effective research and teaching tools in providing an understanding of human anatomy and the development of new therapies. Additionally, animals are increasingly being used by biopharmaceutical companies to test drug toxicity. Hence, the aforementioned applications are expected to drive the market demand in the coming years.
Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/4435
The monkey segment was valued at $1,388 million in 2021 due to physiological similarities to humans in reproduction, neuroanatomy, etc. In China, scientists have created a new monkey research model using CRISPR technology that has enormous potential in different diseases, including Alzheimer’s disease and Parkinson’s disease. . Additionally, in several COVID-19 vaccine research studies, rhesus macaque monkeys have proven to be an effective animal model. Thus, the aforementioned factors are expected to increase segmental growth in the coming years.
Some major findings of the Animal Models Market report include:
- The increasing adoption of CRISPR technology is expected to proliferate industry expansion.
- The increasing number of R&D activities and clinical trials, coupled with the implementation of potential strategies to increase the productivity of drug discovery across the globe, is further invigorating the commercial landscape.
- Competitors are emphasizing strategic collaborations, partnerships, and product launches to gain a major share of the industry and improve their market position.
Browse key industry information spread over 590 pages with 902 market data tables and 18 report figures and graphs, “Animal Models Market Analysis by Animal Type (Mice, Rats, Fish, Birds, Cattle, Pigs, Amphibians, Guinea Pigs, Dogs, Cats, Rabbits, Monkeys, Sheep, Hamsters), Technology (CRISPR, Microinjection, Cell Injection embryonic strains, nuclear Transfer), Applications (Research & Development, Production and Quality Control, Academics, Preclinical Applications), Use (Human and Veterinary), End Use, (Companies, Organizations, Academic and Research Institutes, Contract Research Organizations ( CRO)), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share and Forecast, 2022-2028” in detail with the table of contents:
The nuclear transfer segment exceeded USD 3,247 million in 2021. In recent years, several efficient nuclear transfer techniques have been developed, including somatic cell nuclear transfer (SCNT), sperm gene transfer (SMGT ), etc This cellular approach used for the generation of transgenic research models offers several advantages, including efficient production of transgenic offspring, improved potential for introduction of a wider range of genetic modifications, etc. Likewise, this technique is widely used for various purposes such as establishing the best animal models of human diseases and injuries, discovering biogenic compounds that affect progenitor/stem cells, identifying appropriate in vitro protocols for progenitor cells, etc. . Thus, the many advantages offered by nuclear transfer technology are expected to boost the commercial landscape.
The animal model market of preclinical applications segment is expected to surpass $3,954 million by 2028. The use of animal models in preclinical studies is increasing dramatically owing to several benefits including applications to confirm the efficacy of the target drug and assessment of toxicity, assessment of potential therapies, etc. In preclinical studies, animal models including mice, rats, and monkeys, among others, provide inclusive data and valuable insights that help develop essential safety data relevant to drug discovery and development. New genetically modified animal models are helping preclinical researchers solve several challenges in preclinical activities. Thus, the growing demand for animal models in preclinical studies is expected to drive the expansion of the market over the estimated time frame.
Animal Models Market vThe veterinary segment exceeded USD 3,451 million in 2021. Growing adoption of companion animals for the company, growing demand for animal products, increasing expenditures in animal health, and substantial developments in diagnostics veterinarians will favor industry prospects. The use of animal models is growing as a powerful tool for monitoring disease occurrence, disease diagnosis, and parasite control, among others. Several diseases such as highly pathogenic avian influenza, severe acute respiratory syndrome, hemorrhagic fever and Rift Valley fever have caused significant damage to livestock and pets. Due to emerging or re-emerging zoonoses and other animal infections, there is growing interest in developing therapeutics for these conditions.
The animal model market in Asia-Pacific is expected to exceed approximately USD 2,629 million by 2028. This high market share is mainly attributed to the growing advancements in the field of life sciences and biotechnology, healthcare infrastructure well-developed health system in the country, etc. biotech companies are successfully using emerging technologies including AI to further simulate a drug’s effect on targeted research models. This will further help to reduce the research time and cost involved in drug discovery processes. Thus, thanks to innovations in the pharmaceutical sector and supporting government initiatives, the demand for animal models in the clinical research sector in Japan is expected to increase significantly.
Request to customize this research report @ https://www.gminsights.com/roc/4435
Some of the major market players operating in the animal model industry are Charles River, The Jackson Laboratory, Janvier Labs, Harbor BioMed, and genOway, among others. These players are adopting strategic initiatives such as partnerships, collaborations, new product launches and business expansion to strengthen their product portfolio and market presence.
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, USA, is a global provider of market research and advisory services, offering syndicated and custom research reports as well as consulting services. growth. Our business intelligence and industry research reports provide clients with in-depth insights and actionable market data specially designed and presented to aid in strategic decision-making. These comprehensive reports are designed using proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.